Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
September 19, 2024 08:00 ET
|
Alector, Inc.
--Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene...
Red Cat Holdings to Report Fiscal First Quarter 2025 Financial Results and Provide Corporate Update on Monday, September 23, 2024
September 19, 2024 08:00 ET
|
Red Cat Holdings, Inc.
SAN JUAN, Puerto Rico, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (Nasdaq: RCAT) ("Red Cat'' or the "Company"), a drone technology company integrating robotic hardware and software...
P10 Hosts Investor Day
September 19, 2024 07:30 ET
|
P10, Inc.
DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, will host an Investor Day in New York today, beginning at 8:30 a.m....
Heritage Grocers Group Celebrates Hispanic Heritage Month with Prizes, Authentic Recipes and Community Support Efforts
September 19, 2024 07:00 ET
|
Heritage Grocers Group, LLC
Heritage Grocers Group Celebrates Hispanic Heritage Month with Prizes, Authentic Recipes and Community Support Efforts
ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024
September 19, 2024 07:00 ET
|
ACELYRIN, INC.
LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative...
Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
September 19, 2024 07:00 ET
|
Gain Therapeutics, Inc.
BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
Larimar Therapeutics Announces Three Poster Presentations at the Upcoming International Congress for Ataxia Research
September 19, 2024 07:00 ET
|
Larimar Therapeutics
BALA CYNWYD, Pa., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare...
Die Global Industrial Internet Conference 2024 wurde in Shenyang abgehalten
September 19, 2024 05:49 ET
|
Organizing Committee of the 2024 Global Industrial Internet Conference
SHENYANG, China, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Die Global Industrial Internet Conference 2024 fand vom 11. bis 14. September in Shenyang statt und war ein voller Erfolg. Die diesjährige...
5000+ Forex Companies attending Forex Expo Dubai 2024
September 19, 2024 04:07 ET
|
Forex Expo
DUBAI, United Arab Emirates, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Largest Gathering with 20000+ Visitors and 200+ Exhibitors marking it as one of the largest Expo in the world with just 2 Weeks...
XPENG to Unveil the Future of AI Mobility in Europe at Paris Motor Show 2024
September 19, 2024 04:03 ET
|
Xmotors Limited
PARIS, Sept. 19, 2024 (GLOBE NEWSWIRE) -- XPENG Motors (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese AI mobility company, is set to participate in the Paris Motor Show...